What is Devonian Health Group Inc.?
engages in the development of botanical drugs.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis associated to radiotherapy, as well as in phase 2a clinical trial for ulcerative colitis. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 29.45M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.